NeurologyLive® Mind Moments®

147 Épisodes

1. 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test

   Publié: 10/01/2025
2. 131: Neurology Unwrapped: 2024’s Most Intriguing Conversations

   Publié: 27/12/2024
3. 130: The Promise Behind Cell Therapy Approaches in Epilepsy

   Publié: 13/12/2024
4. 129: Implications of the 2024 AASM Guidelines for Restless Legs Syndrome

   Publié: 29/11/2024
5. 128: Machine Learning Algorithms to Predict Seizure Control in Epilepsy Surgery

   Publié: 15/11/2024
6. 127: Adapting Neuromuscular and Electrodiagnostic Medicine Education for Modern Learners

   Publié: 01/11/2024
7. Special Episode: FDA Approves Sodium Oxybate for Pediatric Narcolepsy

   Publié: 23/10/2024
8. 126: Therapeutic Potential of ATH434 in Multiple System Atrophy

   Publié: 18/10/2024
9. 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis

   Publié: 04/10/2024
10. 124: Therapeutic Updates and Progress in Treating Becker Muscular Dystrophy

    Publié: 20/09/2024
11. 123: Previewing Cleveland Clinic's Epilepsy Summit

    Publié: 06/09/2024
12. 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease

    Publié: 23/08/2024
13. 121: Understanding the Potential Cardiovascular Benefits of Low-Sodium Oxybate

    Publié: 09/08/2024
14. 115: Expanding Access to Ublituximab and AntiCD20s for Multiple Sclerosis

    Publié: 31/07/2024
15. 120: Improving Gait in Multiple Sclerosis Through the Neural Sleeve

    Publié: 26/07/2024
16. 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

    Publié: 12/07/2024
17. Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

    Publié: 09/07/2024
18. 118: Gaining Patient Perspectives on Impact of Narcolepsy

    Publié: 28/06/2024
19. 117: 2024 Consortium of Multiple Sclerosis Centers Annual Meeting Highlights

    Publié: 14/06/2024
20. 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas

    Publié: 31/05/2024